In vitro differentiation of human neuroblastoma cells induced by Sodium phenylacetate (cas 114-70-5)
-
Add time:08/26/2019 Source:sciencedirect.com
Sodium phenylacetate (NaPA) at concentrations ranging from 2 to 6 mM stimulated morphological differentiation of two human neuroblastoma cell lines IMR-32 and UKF-NB-3. These concentrations inhibited growth and DNA synthesis of the cells in a dose dependent manner without significant effect on cell viability. The differentiated cells showed pseudoganglia formation and extension of cellular processes. The morphological differentiation in both cell lines was accompanied by decreased expression of N-myc oncoprotein. These results suggest that NaPA at concentrations, which have been achieved in humans with no significant adverse effects, promotes differentiation of cultured human neuroblastoma cells in association with the reduced expression of the malignant phenotype.
We also recommend Trading Suppliers and Manufacturers of Sodium phenylacetate (cas 114-70-5). Pls Click Website Link as below: cas 114-70-5 suppliers
Prev:Regular ArticleExpression of Transcription Factors During Sodium phenylacetate (cas 114-70-5) Induced Erythroid Differentiation in K562 Cells☆
Next:Regular ArticleSuppression of tumourigenicity, and induction of differentiation of the canine mammary tumour cell line MCM -B2 by Sodium phenylacetate (cas 114-70-5)) - 【Back】【Close 】【Print】【Add to favorite 】
- Related Information
- Dual investigation of lanthanide complexes with cinnamate and phenylacetate ligands: Study of the cytotoxic properties and the catalytic oxidation of styrene08/31/2019
- Evaluation of physically small p-phenylacetate-modified carbon electrodes against fouling during dopamine detection in vivo08/30/2019
- New approach to 4-phenyl-β-aminotetralin from 4-(3-halophenyl)tetralen-2-ol phenylacetate08/29/2019
- Conformational analysis and electronic interactions of some 2-ethylsulfinyl-(4′-substituted)-phenylacetates08/28/2019
- Regular ArticleSuppression of tumourigenicity, and induction of differentiation of the canine mammary tumour cell line MCM -B2 by Sodium phenylacetate (cas 114-70-5)08/27/2019
- Regular ArticleExpression of Transcription Factors During Sodium phenylacetate (cas 114-70-5) Induced Erythroid Differentiation in K562 Cells☆08/25/2019
- Spectroscopic and theoretical study on alkali metal phenylacetates08/24/2019
- Radiopotentiation of human brain tumor cells by Sodium phenylacetate (cas 114-70-5)08/23/2019
- Pharmacokinetics of Sodium phenylacetate (cas 114-70-5) and sodium benzoate following intravenous administration as both a bolus and continuous infusion to healthy adult volunteers08/22/2019
-
Health and Chemical more >
-
Related Products
- Sodium 2,4-dimethylbenzenesulfonate
- SODIUM γ-FLUORO-β-HYDROXYBUTYRATE
- Sodium ((3-methoxy-1-methyl-3-oxo-1-propenyl)amino)phenylacetate
- Sodium (+)-10-camphorsulfonate
- Sodium (2-carbamoylphenoxy)acetate
- Sodium (2-methyl-4-chlorophenoxy)acetate
- Sodium (6R,7R)-3-[(5-methyl-1,3,4-thiadiazol-2-yl)sulfanylmethyl]-8-oxo-7-[[2-(tetrazol-1-yl)acetyl]amino]-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate pentahydrate
- Sodium (C10-16)alkylbenzenesulfonate
- Sodium (R,R)-5-(2-((2-(3-chlorophenyl)-2-hydroxyethyl)amino)propyl)-1,3-benzodioxole-2,2-
- Sodium (S)-lactate


